Cortechs.ai | Case Study: Augmenting Prostate Imaging Programs with OnQ™ Prostate
Cortechs.ai | Case Study: Augmenting Prostate Imaging Programs with OnQ™ Prostate
RSNA 2025
Contact
  • Home
  • /
  • Resources
  • /
  • Case Study: Augmenting Prostate Imaging Programs with OnQ™ Prostate

Case Study: Augmenting Prostate Imaging Programs with OnQ™ Prostate

  • Category: Case studies
  • Product: OnQ Prostate
  • Disease: Prostate cancer

In this case study, Dr. Ross Schwartzberg of Imaging Healthcare Specialists shares how implementing OnQ™ Prostate transformed their prostate MRI program. Learn how Restriction Spectrum Imaging (RSI) technology improves lesion conspicuity, supports more accurate targeting, and strengthens collaboration across the care team.

Fill out the form below to read this case study:


  • Topic: Case studies

More Resources

Cortechs.ai | Case Study: Augmenting Prostate Imaging Programs with OnQ™ Prostate
  • 2 mins

03/04/2026

Cortechs.ai and Siemens Healthineers Partner to Expand Global Access to NeuroQuant® Technologies

NeuroQuant® Lesion Surveillance will be integrated into the Siemens Healthineers Digital Marketplace to advance quantitative brain imaging worldwide.

, ,

Cortechs.ai | Case Study: Augmenting Prostate Imaging Programs with OnQ™ Prostate
  • 2 mins

02/25/2026

Cortechs.ai Announces MFDS (KFDA) Approval of Global-Leading NeuroQuant® V5 Platform in South Korea

MFDS approves NeuroQuant® V5 in South Korea, expanding AI-driven volumetric neuroimaging and clinical decision support.

, ,

Cortechs.ai | Case Study: Augmenting Prostate Imaging Programs with OnQ™ Prostate
  • < 1 mins

02/24/2026

Financial Conflict Of Interest Policy Applicable To NIH Awards

Cortechs.ai | Case Study: Augmenting Prostate Imaging Programs with OnQ™ Prostate
  • 2 mins

02/20/2026

NeuroQuant® PET: FDA 510(k)-Pending Advancement in Molecular Dementia Imaging

FDA 510(k)-Pending NeuroQuant® PET delivers automated, standardized quantification for amyloid, tau, and FDG imaging in dementia care.

,

Cortechs.ai | Case Study: Augmenting Prostate Imaging Programs with OnQ™ Prostate
  • 2 mins

02/19/2026

How Cortechs.ai Protects ePHI: HIPAA‑Aligned Controls—and Beyond

Cortechs.ai’s HIPAA-aligned, defense-in-depth security safeguards ePHI across AI workflows—exceeding baseline compliance standards.

Cortechs.ai | Case Study: Augmenting Prostate Imaging Programs with OnQ™ Prostate
  • 2 mins

02/11/2026

NeuroQuant Normative Database: Advancing Age‑ and Sex‑Specific Brain Volumetry

Learn how the latest updates to the NeuroQuant normative database white paper strengthen age- and sex-specific brain volumetry and enhance clinical confidence.

View our insights
Cortechs.ai | Case Study: Augmenting Prostate Imaging Programs with OnQ™ Prostate
Cortechs.ai | Case Study: Augmenting Prostate Imaging Programs with OnQ™ Prostate

Empowering precision

and clarity in patient care

727 Madison Ave, Suite 29, Covington, Kentucky 41011

Headquarters:

5060 Shoreham Place,
Ste 240, San Diego, CA 92122

Cortechs.ai | Case Study: Augmenting Prostate Imaging Programs with OnQ™ Prostate
Cortechs.ai | Case Study: Augmenting Prostate Imaging Programs with OnQ™ Prostate
  • Solutions
  • © Cortechs.ai 2024
Scroll to Top